leadf
logo-loader
viewNEXTLEAF SOLUTIONS Ltd.

Nextleaf Solutions completes acquisition of its Nextleaf Labs cannabis processing subsidiary

The important milestone for the company allows it to continue the commercialization of its intellectual property (IP) portfolio through the production and wholesale of THC and CBD based oils and concentrates by Nextleaf Labs

NEXTLEAF SOLUTIONS Ltd. -
Nextleaf owns a portfolio of 40 issued patents and over 60 pending patents for the extraction, purification, and formulation of cannabinoids

Nextleaf Solutions Ltd. (CSE:OILS) (OTCQB:OILFF), announced Thursday that it has completed the previously announced acquisition of all of the issued and outstanding shares of Nextleaf Labs Ltd., its subsidiary which holds a Health Canada standard processing and research licenses under the Cannabis Act.

The closing of the acquisition represents an important milestone for the company, allowing it to continue the commercialization of its intellectual property (IP) portfolio through the production and wholesale of THC and CBD based oils and concentrates by Nextleaf Labs.

READ: Nextleaf wins patent for THC-enhancing prodrug THC-O-Acetate

The company owns a portfolio of 40 issued patents and over 60 pending patents for the extraction, purification, and formulation of cannabinoids.

As consideration for the acquisition, Nextleaf issued 1,000,000 common shares to the sole shareholder of Nextleaf Labs at a deemed price of $0.385 per share for aggregate consideration of $385,000. 250,000 Shares were released to the seller on closing, with the remaining 750,000 shares subject to an escrow agreement providing for the release of such Shares in three equal tranches every six months. All shares issued are subject to a four month and one day hold period in accordance with Canadian securities laws.

Nextleaf is Canada's most innovative cannabis extractor, developing technology for extracting and distilling cannabinoids. It provides extraction services and wholesale of THC and CBD oils through Nextleaf Labs, a Health Canada licensed standard processor.

The group’s proprietary closed-loop extraction plant in Metro Vancouver has a design capacity to process 600 kg per day of dried cannabis biomass into distilled oils.

Nextleaf is the first public company to be issued US patents for industrial-scale extraction and distillation of cannabinoids.

Contact the author at [email protected]

Quick facts: NEXTLEAF SOLUTIONS Ltd.

Price: 0.175 CAD

CSE:OILS
Market: CSE
Market Cap: $20.9 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of NEXTLEAF SOLUTIONS Ltd. named herein, including the promotion by the Company of NEXTLEAF SOLUTIONS Ltd. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read